🔴 MEDPAL AI is trading 5.41% down today; no company-specific catalyst identified

MEDPAL AI is trading at £4.02, down 5.41%, after no new company-specific announcement was identified for August 13, 2026.

• The latest listed RNS was the August 11, 2026 update on UK authorisation of Eli Lilly’s once-daily GLP-1 pill.
• Recent operational news remains positive, including record July trading and annualised recurring revenue above £8.6 million, but it does not explain today’s decline.
• The broader market was broadly mixed, with no clear macro catalyst identified.